FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipola... ( TITUSVILLE N.J. Feb. 10 /- Johnson &a...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

Date:2/10/2009

TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional information regarding the company's supplemental New Drug Application (sNDA) for RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection. The sNDA, submitted in April 2008, sought approval for RISPERDAL(R) CONSTA(R) for adjunctive maintenance treatment to delay the occurrence of mood episodes in patients with bipolar disorder who relapsed frequently.

The Agency's complete response outlined questions that need to be addressed prior to granting approval for the new indication, but did not request additional studies.

J&JPRD is currently evaluating the FDA's complete response letter and will work with the Agency to resolve any outstanding questions.

Bipolar disorder is a brain disorder that causes unusual shifts in a person's mood, energy and ability to function. It is often characterized by debilitating mood swings from extreme highs (mania) to extreme lows (depression), and affects 5.7 million, or 2.6 percent, of the American adult population in any given year.(1)

RISPERDAL(R) CONSTA(R) is marketed in the U.S. by Janssen(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and manufactured by Alkermes, Inc. RISPERDAL(R) CONSTA(R) was initially approved for the treatment of schizophrenia in the U.S. in 2003 and is registered in more than 80 countries worldwide. Using Alkermes' proprietary Medisorb(R) drug-delivery technology, the RISPERDAL(R) CONSTA(R) formulation encapsulates risperidone in microspheres made of a biodegradable polymer, which are suspended in a water-based solution and injected into the muscle. Laboratory and clinical research has shown that the microspheres gradually degrade at a set rate to provide therapeutic blood levels of the drug in the blo
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
3. HHS Issues First Department-Wide Report on Personalized Health Care
4. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
5. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
6. CCPM Issues Statement on FDAs GIVE Initiative
7. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
8. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
9. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
10. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
11. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication

Post Your Comments:

(Date:5/19/2013)... Boston, MA (PRWEB) May 19, 2013 ... providing social media training online, has proudly announced that ... for small business has surpassed 175,000 views on YouTube. ... free social media and SEO tips and training for ... see my students find the YouTube tips helpful for ...

(Date:5/17/2013)... Dr. Sparano is Professor of Medicine ... the Albert Einstein College of Medicine and Associate Chairman ... Center. He is also Associate Director for Clinical ... Einstein Breast Cancer Working Group, a multidisciplinary group of ... He also serves as Vice Chair of the National ...

(Date:5/17/2013)... Organ transplant rejection occurs when the transplant recipient,s immune ... attacks it. It was previously thought that T cells, ... activated by molecules known as chemokines in order to ... the Journal of Clinical Investigation , Fadi Lakkis ... to demonstrate that chemokine stimulation of T cells is ...

(Date:5/17/2013)... May 17, 2013 - Elsevier, a world-leading provider of ... announced the publication of a recent study in ... human blastocysts showing that those with an abnormal chromosomal ... they have developed to blastocysts, thereby classifying the risk ... study the same group has undertaken a retrospective study, ...

Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2 Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2 Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3 Breakthrough for IVF? 2 Breakthrough for IVF? 3

[0] YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group [0] Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group [0] Researchers identify signals that direct the immune system to reject a transplanted organ [0] Breakthrough for IVF?

... ... Spectrum Chemicals & Laboratory Products ... and decapper that will increase productivity and lessen injuries due ... advanced ergonomic design and is engineered to improve throughput in ...

... 10 deCODE genetics,(Nasdaq: DCGN ) today announced ... 2009. A conference call to discuss these results and,recent ... tomorrow,Tuesday, August 11, at 8:00am Eastern Daylight Time/12 noon ... The financial results presented below reflect deCODE,s strategic ...

... MONTREAL, Aug. 10 Enobia Pharma, an emerging biotech ... today announced that it raised US$50 million from its current ... used primarily to fund the ongoing development program for ENB-0040, ... and potentially deadly genetic bone disorder for which there is ...

Spectrum Announces New Distribution of AC-Powered Tool for Crimping and Decapping of Laboratory Vials - The CRIMPenstein™deCODE genetics Announces Second Quarter 2009 Financial Results Enobia Raises US$50M from Current Investors in Series C Financing

(Date:5/20/2013)... Boulder, Colo., USA New Geology ... 16 May 2013 cover a wide swath of ... tectonics, oceanography, geophysics, and paleobotany. Locations studied include ... mine at Alpi Apuane, Italy; Ukraine; Mars; and ... , 1. Rubies, jadeite, and plate tectonics;, ...

(Date:5/19/2013)... bacteria that can grow using hydrogen gas as its ... source of carbon. Researchers at the University of ... Meeting of the American Society for Microbiology. , "This ... hydrogen," says Amit Kumar, a researcher on the study ... Lovley Lab Group at the university. , Under the ...

(Date:5/18/2013)... MD (May 19, 2013) The AGA Research Foundation ... and Damian Augustyn Award in Digestive Cancer, which will ... of Medicine at the University of Pennsylvania, Philadelphia, as ... in pancreas development, regeneration and cancer progression. , "The ... in honor of two distinguished clinicians and AGA Legacy ...

[0] New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More [0] Bacteria use hydrogen, carbon dioxide to produce electricity [0] AGA Research Foundation grant furthers digestive cancer research

... , Registration is now open for the Ecological Society ... in Portland, Oregon. The meeting is expected to draw more ... share emerging research. Jane Lubchenco, an Oregon State marine ... will open the six day meeting with a keynote address ...

... Combined, complimentary therapies have the ability to maximize ... spinal cord repair in rat models, according to a ... who published in a recent issue of Cell Transplantation ... "When transplanted, neural stem cells have demonstrated their ...

... April 17, 2012 /PRNewswire-iReach/ -- Global Information ... showing strong growth in the medical devices markets, driven ... Renal Dialysis Equipment Market to 2017 ... increasingly large elderly population are driving rapid growth in ...

Cached Biology News:Registration open for the Ecological Society of America's 2012 Annual Meeting in Portland, Ore. 2 Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies 2 Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 2 Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 3 Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows 4

Registration open for the Ecological Society of America's 2012 Annual Meeting in Portland, Ore.Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows

... Safe Deposit Service ECACC is able to accept ... cGMP for cryo-storage. The cell lines must be ... been produced in accordance with the requirements of ... freedom from mycoplasma, bacteria or fungi. What are ...

Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....

... of expertise in the field of Enzyme-Linked ... most powerful systems on the market. Freedom ... in-microplate tests requiring incubation and washing steps. ... (such as worktable shaker incubators, reader,washer), all ...

... Choice Microsphere/Microarray Stabilizer is a is a ... This product is an aqueous solution ... buffer (phosphate buffered saline), pH 6.6 - ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ...

Biology Products:

cGMP Safe Deposit Facility from European Collection of Cell Cultures (ECACC)Standard and Modified Oligonucleotides Service from Yorkshire Bioscience Ltd ELISA Biopharma from Tecan StabilGuard Choice Microsphere/Microarray Stabilizer from SurModics, Inc.